Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

Hepatology

Volumn 15, Issue 4, 1992, Pages 672-676

  Violi, Francesco ^a   Ferro, Domenico ^a   Basili, Stefania ^a   Quintarelli, Claudio ^a   Saliola, Mirella ^a   Alessandri, Cesare ^a   Cordova, Corrado ^a   Balsano, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BILIRUBIN; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS;

EID: 0026557475     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840150420     Document Type: Article

References (39)

1. Acute upper gastrointestinal hemorrhage: new observation of an old problem
2. Upper gastrointestinal haemorrhage in hepatic cirrhosis: causes and relation to hepatic failure and stress
3. The natural history of gastrointestinal bleeding in patients with alcoholic cirrhosis: definition of a subgroup of patients with high risk of bleeding recurrence [Abstract]
4. Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations
5. Portal hypertension, size of esophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis
6. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patient with cirrhosis of the liver and esophageal varices
7. The course of patients after variceal hemorrhage
8. Hemostasis and liver disease
9. Hemostatic problems in liver disease
10. Laboratory tests and diagnostics procedures in evaluation of liver disease
11. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients
12. Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease
13. Kinetic and functional studies of platelets fibrinogen and plasminogen in patients with hepatic cirrhosis
14. Clinical significance of accelerated fibrinolysis in liver disease
15. Hyperfibrinolysis in cirrhosis
16. The fibrinolytic system in acute and chronic liver injury
17. Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure?
18. Geriunungphisiologische schnellmethode zur bestimmung des fibrinogens
19. Sandwich ELISA for t‐PA antigen employing a monoclonal antibody
20. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay
21. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody‐based enzyme‐linked immunosorbent assay
22. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
23. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis
24. Transection of oesophagus for bleeding oesophagus varices
25. A peek at the Child‐Turcotte classification [Editorial]
26. Abnormal fibrin polymerization in liver disease
27. Estimation of prothrombin in liver disease
28. Prothrombin and haemorrhage
29. Portal pressure, presence of gastroesophageal varices and variceal bleeding
30. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment
31. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of the first variceal hemorrhage
32. Haemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage
33. The platelet fibrinogen receptor
34. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor
35. Evaluation of D‐dimer in patients with liver cirrhosis
36. Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis
37. Endotoxemia, disturbance of coagulation, and obstructive jaundice
38. Impaired fibrinolysis in obstructive jaundice: evidence from clinical and experimental studies
39. Increased procoagulant activity of peripheral blood monocytes in human and experimental obstructive jaundice